Researchers have proposed a set of voice exercise games to help speech quality in people with Parkinson’s disease, which licensed speech therapists found to be a generally feasible, promising approach. If adopted in speech therapy routines, the games could motivate patients to practice more often at the home so…
News
People with Parkinson’s disease appear to have a gut microbiome — the population of microorganisms living in the intestines — that is shifted toward a pro-inflammatory state, a small study suggests. Looking particularly at a pro-inflammatory gut bacterial metabolite called trimethylamine (TMA), its researchers found significantly higher…
Inbrija, an approved treatment for “off” episodes of Parkinson’s disease, has now been launched in Germany. The medication is being sold in Germany by Esteve Pharmaceuticals under an agreement with its developer Acorda Therapeutics. In exchange for supply of the product, Acorda will receive a significant…
The healthcare technology company Koneksa and Northwestern University plan to begin recruiting patients in the third quarter of this year for a study aimed at measuring the severity of vocal abnormalities that can occur in Parkinson’s disease. The clinical trial, which is expected to be completed in 2024, will…
Two European pharma companies have teamed up to create a technology platform that will help people with Parkinson’s disease find the best time to take their medication and make personalized adjustments to their treatment schedules. Gerresheimer AG is partnering with Finnish MedTech start-up Adamant Health Oy on new…
A new method for turning specific human stem cells, called pluripotent stem cells, into neurons that can produce dopamine — the signaling molecule, essential for controlling movement, that is missing in patients with Parkinson’s disease — has now been developed by researchers in the U.S. “Scientists have been trying…
A first study in patients of an intranasal-delivered therapy for Parkinson’s disease is now complete, and early findings support the treatment being safe and leading to improvements in motor function, Zhittya Genesis Medical, the therapy’s developer, announced. Zhittya is offering a first look at the trial data via a…
The buildup of alpha-synuclein in cells and brain tissue in Parkinson’s disease patients is linked to the disruption of processes involved in degrading RNA, the template used for protein production, a study has found. The findings uncover a new biological role for the alpha-synuclein protein, its researchers said. “Our…
A clinical trial will evaluate how well a wearable “exoskeleton” device aids rehabilitation training to improve walking mechanics and neuromuscular function in people with Parkinson’s disease. “Findings linked with the proposed study will likely give substantial solutions to the management of gait and postural disorders (posture, balance, and gait) in [Parkinson’s]…
StrivePD, a Rune Labs‘Â app that collects motor symptom data for people with Parkinson’s disease via measurements recorded by an Apple Watch, has been cleared for use by the U.S. Food and Drug Administration (FDA). “When people with Parkinson’s are prescribed new medications, adjusting how much to take and…
Recent Posts
- Looking back at the changing roles and relationships in Parkinson’s
- Lab-made small molecule may help slow brain disease progression
- New report shows Parkinson’s costs surpass $82 billion in US in 2024
- Pushing forward this Parkinson’s Awareness Month with boldness, grace
- Personalized DBS for Parkinson’s may result from brain study in China